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Activation of T-Cells from Allergic Patients and
Volunteers by p-Phenylenediamine and Bandrowski’s
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Eve Marie Coulter1, Claire Jenkinson1, Ying Wu1, John Farrell1, Brian Foster1, Andrew Smith2, Carolann
McGuire2, Camilla Pease3, David Basketter3, Clodagh King4, Peter Simon Friedmann2, Munir Pirmohamed1,
Brian Kevin Park1 and Dean J. Naisbitt1
Allergic contact dermatitis is commonly associated with exposure to p-phenylenediamine. The aim of this study
was to determine whether p-phenylenediamine (PPD) and/or Bandrowski’s base (BB) stimulate T cells from
allergic patients and volunteers, and to explore the relationship between T-cell immunogenicity and allergy.
Lymphocytes from allergic patients proliferated with PPD and BB (n¼ 8). Lymphocytes from 14/16 non-allergic
individuals also proliferated following stimulation, but only with BB; cord blood lymphocytes failed to respond
(n¼ 6). Glutathione, which prevented BB formation, but not binding of PPD to cells and serum, did not prevent
p-phenylenediamine-specific stimulation of patient lymphocytes. T-cell clones generated from allergic patients
were stimulated separately with PPD and BB, while clones from volunteers proliferated with BB alone. Patient
and volunteer clones secreted IL-4, IL-5, IL-13, TNF-a, MIP-1a, MIP-1b, and RANTES. These data show that
activation of T lymphocytes from allergic individuals alone with PPD represents an important discrimination
between allergic and non-allergic groups. BB-specific T cells are found in both allergic patients and volunteers,
but not in cord blood. Their presence seems to reflect an acquired immune response, which is not translated
into an allergic reaction.
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INTRODUCTION
p-Phenylenediamine (PPD) is widely used in a variety of
industrial processes, including photographic development,
and as an intermediate in the manufacture of azo dyes. PPD
is also one of the most commonly used primary intermediate
components in oxidative hair dyes. A recent report found up
to 1.1% unconsumed PPD in hair dye formulations after final
color development (Rastogi et al., 2006), which illustrates
that hair dyeing exposes individuals to unreacted PPD.
PPD is intrinsically unstable under aqueous conditions;
auto-oxidation leads to the formation of an electrophilic
primary quinonediimine intermediate, which is susceptible
to sequential self-conjugation. A rearrangement product of
these oxido-conjugation reactions is the trimer Bandrowski’s
base (BB) (Figure 1; Picardo et al., 1990).
PPD and BB (Bandrowski’s base) are classified as strong
and extreme sensitizers, respectively, based on their ability to
promote lymphocyte proliferative responses in lymph nodes
of topically exposed mice (Warbrick et al., 1999; White et al.,
2006). In human volunteers, 50–100% of individuals treated
with a topical solution of PPD at concentrations of 1–30%
showed evidence of sensitization (Kligman, 1966; Marzulli
and Maibach, 1974). The incidence of allergic reactions
to PPD is on the increase, especially in the young, which has
been attributed to more people dyeing their hair at a younger
age (McFadden et al., 2007). Although these data suggest that
PPD and BB are immunogenic, the nature of the chemical
entity that interacts with immune cells has not been fully
elucidated.
Studies by Krasteva et al. (1993) have shown that BB,
but not PPD or primary oxidation products, stimulated T cells
from allergic patients. However, more recent work with
cloned T cells from PPD allergic individuals provides
evidence to suggest that PPD and BB might actually stimulate
proliferation of T cells via two independent mechanisms
(Sieben et al., 2002). PPD associated non-covalently with
major histocompatibility molecules was found to stimulate
certain T cells directly without a requirement for processing,
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while BB-stimulated T cells via a classical hapten mechanism
involving both irreversible binding and processing. Impor-
tantly, in both studies, neither PPD nor BB stimulated proli-
feration of lymphocytes from non-allergic individuals. In
view of the fact that different groups have generated
apparently conflicting results, we have assessed the ability
of PPD and BB to stimulate T cells and analyzed in parallel
the degradation and protein reactivity of each compound in
solution.
We report that circulating CD4þ T cells from allergic
patients are stimulated with both PPD and BB. Moreover,
in contrast to previous reports, CD4þ T cells from most
non-allergic volunteers are specifically stimulated, but only
with BB. These data show that BB is antigenic even in indivi-
duals who have never dyed their hair, suggesting possible
sensitization through other routes such as clothing dyes that
contain PPD. However, since PPD-specific T-cell responses
can be demonstrated additionally in allergic patients, this
suggests that PPD, but not BB, may play an important role
in allergic sensitization.
RESULTS
Lymphocyte proliferation with p-phenylenediamine and BB
Lymphocytes from allergic patients proliferated in vitro in
response to both BB and PPD. After culture with BB (5 mM),
the mean stimulation index (SI) was 64.1744.2. Lympho-
cytes from seven (out of eight) patients also proliferated
following stimulation with PPD (SI with 5 mM PPD; 18.476.9)
(Figure 2a). Lymphocyte proliferation associated with both
PPD and BB exposure was concentration-dependent. PPD
and BB concentrations between 0.1–50 mM stimulated
a significant proliferative response, whereas concentrations
of 100mM and above inhibited the proliferation, which is
likely to be due to the direct toxic effects of PPD and BB, as
reported previously with dendritic cells (Coulter et al., 2007).
By contrast, lymphocytes from healthy volunteers showed
no proliferation in vitro with fresh PPD stimulation. Lympho-
cytes from 14 out of 16 volunteers did however respond
following stimulation with BB (1–50mM; Figure 2b). The
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Figure 1. Scheme depicting proposed PPD oxidation.
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Figure 2. Antigen-specific stimulation of lymphocytes from allergic patients, volunteers and cord bloods. Mean proliferative response of lymphocytes
from (a) eight allergic patients and (b) 16 volunteers, stimulated with PPD and BB. (c) Maximum proliferation of PPD- and BB-stimulated lymphocytes
isolated from patient and volunteer cohorts. (d) Comparison of BB-specific proliferation of peripheral blood lymphocytes from allergic patients (n¼ 6) and
volunteers (n¼ 9) and cord blood lymphocytes (n¼ 6). Coefficient of variation was consistently less than 20%.
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strength of the proliferative response to BB was not signifi-
cantly different when allergic patients and healthy volunteers
were compared. Lymphocyte proliferation from the two non-
responding volunteers was assessed on four separate occasions
with different batches of BB and no significant proliferation
above control levels was observed (SI less than 2). Figure 2c
illustrates the maximal responses of patient and volunteer
lymphocytes, when incubated with PPD or BB. Although large
inter-individual variations were seen with both patient and
volunteer cells, the data presented clearly show consistent
responses of patient and volunteer cells to BB, whereas only
patient cells responded to PPD.
To explore why volunteer lymphocytes do not respond
following PPD exposure despite in situ BB generation,
lymphocytes were incubated with PPD aged in cell-free
culture medium for 4–72 hours. In contrast to lymphocytes
incubated with fresh PPD, which were not specifically
stimulated (SI less than 1.5), aged PPD (1–10 mM) stimulated
lymphocyte proliferation at each time point tested (4 hours,
maximum SI 2.3; 24–72 hours, maximum SI 2.9–4.8).
It was also important to determine whether known
previous exposure to permanent hair dye formulations was
related to an increased proliferative response with BB. The
maximal proliferative response with BB and the BB concen-
trations associated with a significant proliferation did not
differ when hair dye exposed and non-exposed volunteers
were compared (hair dye exposed: mean SI at 1 mM, 6.8;
10 mM, 17.4; 50mM, 10.3; non-hair dye exposed: mean SI at
1 mM, 9.3; 10 mM, 17.4; 50 mM, 10.2).
As a further control for the possibility that responses to BB
reflect specific T-cell recognition or that BB was acting as a
simple mitogen, cord blood lymphocytes were cultured with
BB. No responses were obtained (Figure 2d).
p-Phenylenediamine and BB preferentially stimulate a CD4þ
T-cell response
To assess the involvement of CD4þ and CD8þ T cells in
PPD- and BB-mediated lymphocyte stimulation, CD4þ and
CD8þ T cells were depleted from patient and volunteer
samples before analysis of proliferation. Cell sorting was
associated with a depletion of greater than 98% CD4þ and
CD8þ T cells from peripheral blood. Depletion of CD4þ
T cells inhibited PPD- and BB-specific stimulation of patient
and volunteer cells, whereas depletion of CD8þ T cells did
not significantly alter the response (Figure 3).
Patients T cells are specifically stimulated with PPD
Previous studies have shown that patient’s T cells are stimu-
lated following in vitro exposure to PPD (Sieben et al., 2002).
However, PPD oxidation, self-conjugation, protein binding,
and BB formation in culture was not controlled for, and
hence, the observed T-cell responses may represent antigen
stimulation with a PPD-related product, not PPD itself.
To determine whether PPD specifically stimulates allergic
patient T cells, the stability of PPD and formation of PPD
oxidation products were measured. PPD was found to
degrade rapidly in culture (Figure 4a and c). Unbound BB-
and PPD-derived oxidation products conjugated irreversibly
to cellular and serum protein were the major products
detected (Figure 4a and b). Binding of radioactive material
to serum protein was approximately four-fold higher than to
cellular protein. Importantly, the rate of PPD degradation,
and extent of formation of BB and irreversible adducts did
not differ in incubations containing patient and volunteer
lymphocytes. Addition of glutathione (1mM) to cell culture
medium prevented BB formation for up to 24 hours (Figure
4a) and lowered, but did not prevent irreversible binding
of PPD-derived material to cellular and serum protein
(Figure 4b).
To evaluate whether patient cells are specifically stimu-
lated with PPD, lymphocytes were incubated with PPD for
4 and 24 hours in the presence or absence of glutathione.
Cells were washed to remove unbound PPD and PPD
degradation products and suspended in fresh medium for
the remainder of the incubation. Importantly, in the presence
of glutathione, lymphocytes were not exposed to BB. Incu-
bation of lymphocytes with PPD (7glutathione) for 4 hours
did not stimulate a significant proliferative response (data
not shown). In contrast, a 16-hour incubation with PPD
was associated with significant proliferation (Figure 4d). The
levels of PPD-specific proliferation in the presence and
absence of glutathione were comparable (ie, glutathione did
not inhibit the response). Volunteer lymphocytes incubated
with PPD for 16 hours and then washed were not stimulated.
Generation of antigen-specific T-cell clones from patients and
volunteers and analysis of cytokine/chemokine secretion
Following limiting dilution and clonal expansion, low
numbers of BB-specific CD4þ T-cell clones were generated
from allergic patients (no BB, 2,333.1 c.p.m.; 5 mM BB,
5,993.9 c.p.m.; 10 mM BB, 6,075.4 c.p.m.; n¼30) and volun-
teers (no BB, 2,286.4 c.p.m.; 5 mM BB, 10,708.8 c.p.m.; 10 mM
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Figure 3. Antigen-specific stimulation of CD4þ T-cells from allergic
patients and volunteers. Stimulation of CD4þ T cells from (a) allergic
patients and (b) volunteers with PPD and/or BB. CD4þ and CD8þ T cells
were depleted from peripheral blood before analysis of antigen stimulation
using antibody-labeled magnetic beads. Data show one of three
representative experiments using lymphocytes from different individuals.
Coefficient of variation was consistently less than 20%.
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BB, 8,608.0 c.p.m.; n¼ 44). Proliferation of T-cell clones
following BB stimulation was concentration dependent
(Figure 5a); no specific stimulation was observed with PPD.
PPD-specific CD4þ T-cell clones were also generated,
but only using lymphocytes from allergic patients (no
PPD, 2,333.1 c.p.m.; 5 mM PPD, 5,993.9 c.p.m.; 10 mM PPD,
6,075.4 c.p.m.; n¼ 30). The proliferative response using
different PPD concentrations is shown in Figure 5a. T-cell
clones proliferated only in the presence of PPD (Figure 5b),
providing conclusive evidence that T cells from allergic
patients are additionally stimulated by PPD or a PPD degra-
dation product.
Previously, Sieben et al. (2002) reported high levels of
IL-4 and IL-5 secretion from PPD- or BB-stimulated T cells
from allergic patients. To obtain a global analysis of cytokine/
chemokine secretion and to explore possible differences
between patient and volunteer clones, cytokine levels were
measured in supernatants following antigen stimulation using
Luminex technology. In addition to the previously reported
increase in IL-4 and IL-5, stimulated T-cell clones were also
found to secrete high levels of IL-13 and moderate levels of
tumor necrosis factor-a (TNF-a), macrophage inflammatory
protein-1a (MIP-1a), MIP-1b and RANTES (Tables 1 and 2).
No apparent difference in secretion profile was observed
when (1) PPD- and BB-specific patient clones or (2) patient
and volunteer clones were compared.
DISCUSSION
Topical application of low concentrations of the PPD oxi-
dation product BB to mice is associated with increased
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proliferation of draining lymph-node cells (White et al.,
2006). In PPD allergic patients, BB has been shown to stimu-
late lymphocyte proliferation ex vivo (Krasteva et al., 1993;
Sieben et al., 2002). Furthermore, T cells have been cloned
from certain patients and shown to be BB specific. T cells
were CD4þ and proliferated with BB via a classical hapten
mechanism, dependent on processing and thus presumably
an irreversible binding interaction between BB and protein.
We have also shown that BB stimulated CD4þ lymphocyte
proliferation in allergic patients (Figure 2a). In contrast to
previous studies investigating T-cell responses with PPD
and PPD oxidation product (Krasteva et al., 1993; Sieben
et al., 2002), CD4þ lymphocytes from most volunteers, with
or without known hair dye exposure (14/16), showed
proliferative responses to BB (Figure 2b). It should be pointed
out that PPD is found in dark blue and black clothing dyes,
so virtually everyone is exposed to contact with PPD.
Importantly, detection of BB-specific stimulation of volunteer
lymphocytes was seen by two independent research groups
(Liverpool and Southampton) using the same cell culture
methodologies. Furthermore, different batches of BB, which
contained no detectable PPD or other major impurities by
liquid chromatography-mass spectrometry, stimulated patient
and volunteer cells to the same extent.
T-cell clones were generated from allergic patients and
volunteers to explore whether the observed lymphocyte
stimulation with BB represents a true antigen-specific
response. CD4þ BB-specific T-cell clones were generated,
but only in low numbers (Figure 5a), which supports
an antigen-specific pathway for lymphocyte stimulation. BB
did not stimulate cord blood cells, indicating that BB-specific
lymphocyte stimulation is dependent on prior exposure
(Figure 2d). This conclusion is supported by unpublished
data from our laboratory using mice showing that T cells are
only stimulated with BB after in vivo exposure. Lymphocytes
from 2/16 volunteers showed no response to BB (although
they proliferated in the presence of a protein antigen, tetanus
toxoid; 5 mgml1; results not shown), despite repeated
testing, possibly suggesting that these individuals have not
been exposed to BB concentrations above an immunogenic
threshold.
These data clearly show that BB is an antigenic deter-
minant for T cells from both PPD allergic patients and
volunteers. Ex vivo T-cell stimulation with BB is seen even
in individuals that have never dyed their hair. The reactivity
seems to reflect T-cell sensitization, but not allergy, similar
to T-cell responses in protective immunity in which there are
no features of hypersensitivity. It is possible that BB might
stimulate regulatory T-cell response in volunteers, compar-
able with the findings of Cavani et al. (1998, 2003). Our data
examining cytokine secretion from a limit cohort of stimu-
lated T-cell clones did not detect the presence of regulatory
cytokines such as IL-10 and as such the role of regulatory
T cells in the prevention of contact dermatitis is an area that
warrants further investigation.
Recently, White et al. (2006) showed that when PPD
patch test-positive allergic patients were exposed to gradually
increasing topical concentrations of BB, positive (weak)
patch tests were obtained in only 16%. This suggests that
BB-specific T cells may not actually play a pathogenic role
in PPD allergy. In support of this hypothesis, data presented
show that PPD-induced CD4þ lymphocyte responses were
only found with cells from clinically allergic patients but not
from volunteers (Figure 2a). Most volunteers who have dyed
their hair have been exposed to PPD on several separate
occasions, thus ruling out the possibility that they could have
been sensitized to PPD, but not had a chance to react due to
the absence of re-exposure. In preliminary unpublished
experiments, we have shown that antigen stimulation of
PPD-enriched lymphocytes from allergic patients, but not
volunteers, has the capacity to kill autologous target cells.
Thus, in ongoing experiments we are exploring the cyto-
toxic potential of patient and volunteer lymphocytes and
T-cell clones, and how this relates to the development of
PPD-mediated contact dermatitis.
In view of the fact that PPD is so intrinsically unstable, it
was important to determine whether these data represent a
true PPD-specific response, or alternatively, might PPD
be oxidized more readily in patient cells (ie, are the T cells
actually stimulated with BB).
In initial experiments, in vitro distribution of PPD and
irreversible binding of PPD-related products to cells and
serum was quantified over 130 hours, using lymphocytes
from allergic patients and volunteers. PPD concentrations
were found to decrease rapidly in culture (Figure 4a and c).
Disappearance of PPD was associated with formation of
unbound BB (Figure 4a) and PPD-derived material bound
irreversibly to both cellular and serum proteins (Figure 4b).
No significant difference was seen in either the rate of PPD
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degradation or the quantity of PPD bound irreversibly to
protein when patients and volunteers were compared. Thus,
differences in cellular distribution of PPD do not account for
the diverse T-cell response in patients and volunteers. In
subsequent experiments, culture medium was supplemented
with glutathione (1mM) using a protocol developed to reduce
the drug (metabolite) antigen nitroso sulfamethoxazole
(Burkhart et al., 2001; Naisbitt et al., 2002; Farrell et al.,
2003), and stimulation of patient’s lymphocytes was mea-
sured. Glutathione prevented BB formation but not irrever-
sible binding of PPD-derived material to protein (Figure 4a
and b). Lymphocytes cultured with PPD and glutathione
for 24 hours were specifically reactive, when compared
with vehicle control-treated cells (Figure 4d; the strength of
the proliferative response was similar to that seen with PPD
alone). These data provide evidence to suggest that PPD-
allergic patients indeed produce lymphocytes that react with
native PPD. This was confirmed by the observation that
stimulation with PPD resulted in generation of PPD-specific
T-cell clones in lymphocytes from patients but not volunteers
(Figure 5).
The mechanism of T-cell activation by PPD has not been
fully elucidated. Sieben et al. (2002) presented data to suggest
that PPD can be recognized by T cells through a processing-
independent pathway. Since antigen-presenting cells pulsed
with PPD for 4 hours failed to stimulate clones, the authors
suggested that PPD might bind directly to major histocom-
patibility and/or the T-cell receptor. Herein, we have shown
Table 1. Clinical details of patients and volunteers
Age Sex
Previous hair
dye use
PPD
allergy Other allergy
Months since
reaction
Patch test
result LTT
PPD BB
Allergic patients
1 59 F Yes Yes 18 ++ +1 +
2 66 F Yes Yes Unknown ++ + +
3 65 Yes Yes 25 ++  +
4 63 F Yes Yes 60 ++ + +
5 52 M Yes Yes Red, orange, and blue dye,
potassium dichromate
24 ++ + +
6 41 F Yes Yes 28 ++ + +
7 65 F Yes Yes Nickel, orange dye 72 ++ + +
8 45 F Yes Yes 22 ++ + +
Volunteers
9 25 F Yes (M)2 No Np  +
10 26 F Yes (M) No Septrin Np  +
11 49 F Yes (M) No Np  +
12 26 F Yes (M) No Np  +
13 51 F Yes (M) No Np  +
14 34 F Yes (M) No Np  +
15 30 F Yes (M) No Np  +
16 34 M Yes (M) No Np  +
17 27 M No No Np  +
18 23 M No No Np  +
19 28 M No No Np  +
20 65 M No No Np  +
21 34 M No No Np  +
22 45 M No No Np  +
23 38 M No No Np  
24 33 M Yes (M) No Tetracycline Np  
BB, Bandrowski’s base; F, female; LTT, lymphocyte transformation test; M, male; Np, not performed; PDD, p-phenylenediamine.
1+ indicates stimulation index of 2 or above. Concentration-dependent effect shown elsewhere in the manuscript.
21, 2, M (multiple) indicate the number of known hair dye exposures.
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that a 4-hour incubation of PPD with lymphocytes from
allergic patients failed to stimulate proliferation, whereas a
longer incubation period was associated with a PPD-specific
proliferative response. Importantly, 24 hours is the time
needed for (1) maximum irreversible binding of PPD to
cellular and serum protein and (2) antigen processing, which
indicates that a PPD associated covalently with protein might
be an antigenic determinant. This proposal is similar to the
findings of Pickard et al. (2007) showing that dinitrochloro-
benzene forms irreversibly bound conjugates with protein to
activate T cells from allergic individuals. Furthermore, the
group of Lepoittevin have shown using nuclear magnetic
resonance spectroscopy that p-benzoquinonediimines can
react with nucleophilic residues on amino acids through a
set of complex mechanisms (Eilstein et al., 2006), indicating
a potential route to haptenation of protein, which does not
rely on BB formation and is thus consistent with the data
presented herein.
Since PPD is converted readily to BB in culture, it is impor-
tant to consider why PPD exposure to volunteer lymphocytes
does not stimulate a T-cell response via BB formation. In
this respect, volunteer lymphocytes were incubated with
fresh PPD and PPD aged in cell-free culture medium for
4–72 hours. In contrast to lymphocytes incubated with fresh
PPD that do not respond, an antigen-specific T-cell response
was observed with aged PPD at each time point studied.
These data confirm that in situ BB generation does indeed
stimulate an antigen-specific T-cell response, but only if PPD
is aged in the absence of cells. There are several possible
explanations as to why PPD aged in the presence of cells
does not stimulate lymphocytes. First, PPD degradation is
associated with the formation of irreversible bound cellular
adducts (Figure 4b), and this process in essence will decrease
the amount of BB formed. Subsequently, higher PPD concen-
trations required to generate stimulatory BB concentrations
may inhibit, rather than stimulate, T-cell proliferation.
Second, when BB is formed in situ in the presence of cells,
the length of BB exposure will be less, effectively reducing its
stimulatory capacity.
Contact dermatitis associated with exposure to chemicals
such as PPD has, until recently, been thought to be instigated
by IFN-g producing T cells. However, it has been postulated
that IL-4-producing T cells might play an important role in
the development of tissue pathology (Salerno et al., 1995). In
support of this proposal, high levels of IL-4 and the related
cytokine IL-13 are detected in skin biopsy samples from
allergic patients (Asherson et al., 1996; Neis et al., 2006).
Sieben et al. (2002) reported high levels of IL-4 and IL-5
secretion by PPD- and BB-reactive T-cell clones from hair
dye allergic patients. Herein, we present similar data with
patient clones and additionally demonstrate the same pattern
of cytokine secretion by BB-stimulated clones from volun-
teers (Table 2). In line with the histological observations
described above, clones from patients and volunteers
were also found to secrete high levels of IL-13. As Luminex
technology permitted a more global analysis of cytokine/
chemokine secretion, stimulated T-cell clones were shown to
secrete TNF-a, which might relate to the inflammatory
symptoms associated with contact dermatitis, and the CCR5
ligands MIP-1a, MIP-1b, and RANTES. Expression of these
chemokines has been shown to be increased in the presence
of TNF-a and IL-13, while increased expression is also
associated with various immunological diseases including
rheumatoid arthritis and systemic lupus erythematous (Torikai
et al., 2007; Vila et al., 2007). The role of MIP-1a, MIP-1b, and
RANTES in contact dermatitis warrants further investigation.
In conclusion, data presented clearly show that lympho-
cytes from patients and most volunteers proliferate when
stimulated with BB. However, PPD provides an additional
chemical signal to specifically stimulate T cells from allergic
patients. These data represent an important laboratory-based
discrimination between allergic and non-allergic groups.
Further investigations are planned to confirm that PPD-
specific T cells are indeed the major effector cells in PPD
Table 2. Cytokine and chemokine secretion from PPD- or BB-stimulated T-cell clones
Cytokine/chemokine (pgml1)1
Clone specificity Clone origin IL-4 IL-5 IL-13 IFN-c TNF-a MIP-1a MIP-1b RANTES
PPD Patient 535 125 3,059 ND 113 2,905 1,538 316
PPD Patient 528 360 o5,000 ND 194 634 452 221
PPD Patient 1,129 4,023 o5,000 ND 224 1,986 3,210 3,288
BB Patient ND 189 o5,000 ND 44 838 4,752 213
BB Patient 63 85 o5,000 ND 305 3,968 o5,000 1,526
BB Patient 49 597 o5,000 ND 586 6,376 o5,000 2,574
BB Patient 1,427 2,598 o5,000 20 1,191 4,149 o5,000 1,561
BB Volunteer 46 ND o5,000 10 122 787 1,792 2,697
BB Volunteer 1,754 630 o5,000 ND 129 853 1,078 740
BB, Bandrowski’s base; IFN-g, interferon-g; IL, interleukin; ND, not determined; PPD, p-phenylenediamine.
1Levels of the cytokines and chemokines IL-1b, IL-1a, TGFa, IL-8, IL-10, IL-12, IL-15, IL-17, eotaxin, MCP-1, and IP-10 in PPD- or BB-treated samples were
not significantly different from that of solvent-treated controls.
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sensitization. In particular, we are generating PPD-specific
T-cell clones directly from blood and inflamed skin of
patients and volunteers to assess in detail regulatory and
effector mechanisms and distinct migratory characteristics of
specific T cells.
MATERIALS AND METHODS
Donor characteristics
Peripheral blood mononuclear cells were isolated from venous
blood obtained from eight PPD-allergic, patch test-positive patients,
and 16 healthy volunteers. In addition, peripheral blood mono-
nuclear cells were isolated from six cord blood samples taken after
the cords had been clamped. Approval for the study was obtained
from Liverpool local research ethics committee and the South-
ampton and South West Hampshire ethics committee; informed
written consent was obtained. The study was conducted according
to Declaration of Helsinki Principles. The details of the patients and
volunteers are shown in Table 1.
Cell culture medium
Culture medium consisted of Rosewell Park Memorial Institute-1640
supplemented with pooled heat-inactivated human AB serum (10%,
v/v), HEPES (25mM), L-glutamine (2mM), transferrin (25 mgml1),
streptomycin (100mgml1), and penicillin (100Uml1).
Cell lines and chemicals
Epstein–Barr virus -transformed B-cell lines (referred to as antigen
presenting cells) were generated using supernatant from the
Epstein–Barr virus producing cell line B9–58. PPD was obtained
from Sigma Chemical Co. (Poole, Dorset, UK). BB was obtained
from ICN Biomedicals Inc. (Aurora, OH). [14C]PPD (specific activity
60mCimmol1) was synthesized by GE Healthcare (Bucks, UK).
All chemicals were prepared as stock solutions (10mgml1) in
culture media and DMSO (4:1 v/v) and diluted as required.
Chromatography-grade solvents were products of Fisher Scientific
(Loughborough, Leicestershire, UK). All other reagents were
obtained from Sigma Chemical Co.
Determination of lymphocyte proliferation
Proliferation of patient and volunteer lymphocytes with PPD and BB
(both 0.1–500 mM; 7glutathione [1mM]) was quantified by measure-
ment of [3H]thymidine, as described previously (Pichler and Tilch,
2004). In separate experiments, lymphocytes were incubated with
PPD (1–25 mM) aged in cell culture medium for 4–72 hours. Proli-
ferative responses were calculated as stimulation indices (SI; c.p.m.
in drug-treated cultures/c.p.m. in cultures with DMSO alone).
In addition, to assess the involvement of CD4þ and CD8þ
T cells in the antigen-specific response, CD4þ and CD8þ T cells
were depleted from peripheral blood using immunomagnetic
microbeads coated with anti-CD4þ or anti-CD8þ antibodies and
magnetic cell sorting (Miltenyi Biotec, Bisley, UK) before analysis
of PPD- and BB-specific lymphocyte proliferation. The purity of the
sorted T-cell lines was determined by flow cytometry.
Determination of the chemical fate of p-phenylenediamine in
culture
[14C]PPD (50 mM [0.2 mCi];7glutathione [1mM]) was incubated with
lymphocytes (1.5 106; total volume 1ml) in cell culture medium at
371C. At 0, 4, 24, 48, 72, and 130hours, 100-ml aliquots were taken
and analyzed by radiometric HPLC and liquid chromatography-mass
spectrometry, using previously described experimental conditions
(Coulter et al., 2007). To determine whether PPD binds covalently to
protein, cells and supernatant were separated by centrifugation and
irreversible binding of radioactive compound to cellular or serum
protein was determined by exhaustive solvent extraction, as
described previously (Pirmohamed et al., 1995).
Investigation of the mechanism of PPD-mediated lymphocyte
proliferation
To confirm that lymphocytes from allergic patients were actually
stimulated with PPD or a primary oxidation product, in addition to
BB, lymphocytes were incubated with PPD in the presence or
absence of glutathione (1mM), which prevents BB formation, but not
irreversible binding of PPD-derived material to cells/serum. After
4 and 24 hours, lymphocytes were washed repeatedly, to remove
soluble PPD, suspended in fresh medium and cultured at 371C for
the remainder of the proliferation assay.
Generation of T-cell clones
PPD and BB stimulated lymphocytes from allergic patients and
volunteers were cloned by limiting dilution using previously
described methodology (Schnyder et al., 1997; Wu et al., 2006).
To test the specificity of the clones, T cells (0.5 105) were incu-
bated with irradiated (60Gy) autologous antigen-presenting cells
(0.1 105) and the compound that the lymphocytes were initially
stimulated with. After 48 hours, [3H]thymidine was added and
proliferation determined. CD phenotype and monoclonality were
determined by flow cytometry (Naisbitt et al., 2003).
Specificity of the T-cell clones and analysis of cytokine/
chemokine production
Irradiated antigen-presenting cells (0.1 105) and T-cell clones
(0.5 105) were incubated with PPD or BB (both 5–50 mM) for
analysis of proliferation. Supernatants were collected before the
addition of [3H]thymidine, pooled for each condition and stored at
701C. Concentrations of IL-1a, IL-1b, IL-4, IL-5, IL-6, transfoming
growth factora, IL-8, IL-10, IL-12, IL-13, IL-15, IL-17, IFN-g, TNF-a,
eotaxin, MCP-1, sCD40L, MIP-1a, MIP-1b, interferon-inducible
protein-10 (IP-10), and RANTES were measured in supernatants
using the human cytokine/chemokine LINCOplex multiplex assay kit
(manufactured by LINCO Research Inc., Hampshire, UK). Cytokine
content was measured using a Liquichip 100 workstation (Qiagen
Ltd, West Sussex, UK) with LiquiChip IS 2.3 software.
Statistical analysis
The Mann–Whitney test was used for comparison of control and test
values, accepting Po 0.05 as significant.
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